31 January 2022 - Today, the U.S. FDA approved a second COVID-19 vaccine.
The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.